Wednesday, May 27, 2026Today's Paper

AI Finance Hub

Topic

Healthcare Regulation

1 post
IBRX Stock Forecast & Analysis: Growth, Risks, and Catalysts

IBRX Stock Forecast & Analysis: Growth, Risks, and Catalysts

Is IBRX stock a buy? Get the latest on ImmunityBio, from Anktiva's sales surge and crucial 2027 PDUFA date to FDA warning letters and class action lawsuits.

May 27, 2026·12 min read